The acquisition grows Stryker’s soft tissue fixation portfolio, according to a June 3 news release. Artelon’s products have technology designed to enhance biological and mechanical ligament and tendon reconstruction, and have been used in more than 60,000 cases worldwide.
The transaction is subject to customary closing conditions. Terms of the deal weren’t disclosed.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
